CCM
MRNA icon

Cribstone Capital Management’s Moderna MRNA Stock Holding History

Cribstone Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$144K Hold
800
– – 0.08% 121
2022
Q3 		$95K Hold
800
– – 0.06% 134
2022
Q2 		$114K Hold
800
– – 0.07% 122
2022
Q1 		$138K Hold
800
– – 0.08% 117
2021
Q4 		$203K Buy
+800
New +$234K 0.11% 106
2021
Q1 		– Sell
-30
Closed -$3K – 343
2020
Q4 		$3K Hold
30
– – ﹤0.01% 289
2020
Q3 		$2K Hold
30
– – ﹤0.01% 264
2020
Q2 		$2K Hold
30
– – ﹤0.01% 294
2020
Q1 		$1K Buy
+30
New +$690 ﹤0.01% 318

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cribstone Capital Management's MRNA Position: Q4 2022 in Review

Cribstone Capital Management held its Moderna (MRNA) position steady in Q4 2022 at 800 shares worth $144K. The position accounts for 0.08% of the portfolio, ranked #121.

Cribstone Capital Management first reported a position in MRNA in Q1 2020 and has held it in 9 quarters since. The position peaked at $203K in Q4 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Cribstone Capital Management held 800 shares of Moderna worth $144K as of Q4 2022.
  • Cribstone Capital Management left its Moderna share count unchanged in Q4 2022.
  • Moderna made up 0.08% of Cribstone Capital Management's portfolio in Q4 2022, its #121 holding.
  • Cribstone Capital Management first reported a position in Moderna in Q1 2020 and has held it in 9 quarters since.
  • Cribstone Capital Management's Moderna position peaked at $203K in Q4 2021.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Cribstone Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.